Praxis Precision Medicines will present late-stage epilepsy and movement disorder data at the AAN 2025 Annual Meeting in San Diego. Praxis Precision Medicines, Inc. announced its participation in the ...
Differences in brain connectivity are linked to several neurodevelopmental disorders, yet scientists still struggle to ...
Crossing the Blood–Brain Barrier: Drug Development Strategies for Central Nervous System Disorders
The Blood-Brain Barrier (BBB) is a highly selective interface that protects the brain by regulating the entry of nutrients, signaling molecules, and ...
The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...
The AHA scientific statement calls for a life-course approach to brain health that integrates cognitive, emotional, ...
Sleep is a complex biological process, with numerous evolutionarily-gained functions. Despite its indisputable biological importance, much remains unknown about sleep, including the bidirectional ...
Gene therapy and ASOs have the potential to offer new therapeutic opportunities, and possibly cures, to patients where few or no treatment options exist for their disease. The Forum on Neuroscience ...
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics is launching to create the next generation of regenerative medicines to restore hope for people affected by CNS disorders. The company has completed a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results